Blood vessels as targets in tumor therapy

References

• Pittman RN. Oxygen transport and exchange in the microcirculation. Microcirculation. 2005;12:59–70.
   PubMed Web of Science ®Google Scholar
• Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta. 2004;1654:13–22.
   PubMed Web of Science ®Google Scholar
• Burri PH, Hlushchuk R, Djonov V. Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn. 2004;231:474–88.
   PubMed Web of Science ®Google Scholar
• Kopp HG, Ramos CA, Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol. 2006;13:175–81.
   PubMed Web of Science ®Google Scholar
• Fukumura D, Jain RK. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem. 2007;101:937–49.
   PubMed Web of Science ®Google Scholar
• Baluk P, Hashizume H, McDonald DM. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev. 2005;15:102–11.
   PubMed Web of Science ®Google Scholar
• Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983–5.
   PubMed Web of Science ®Google Scholar
• Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS. 2005;209–31.
   PubMedGoogle Scholar
• DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer. J Biol Chem. 1995;270:7717–23.
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843–5.
   PubMed Web of Science ®Google Scholar
• Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S, Wirzenius M, Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 2008;454:656–60.
   PubMed Web of Science ®Google Scholar
• Brekken RA, Thorpe PE. VEGF-VEGF receptor complexes as markers of tumor vascular endothelium. J Control Release. 2001;74:173–81.
   PubMed Web of Science ®Google Scholar
• Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J. 2011;437:169–83.
   PubMed Web of Science ®Google Scholar
• Xu D, Fuster MM, Lawrence R, Esko JD. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J Biol Chem. 2011;286:737–45.
   PubMed Web of Science ®Google Scholar
• Geretti E, Shimizu A, Klagsbrun M. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis. 2008;11:31–9.
   PubMed Web of Science ®Google Scholar
• Li X, Tjwa M, Van Hove I, Enholm B, Neven E, Paavonen K, Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol. 2008;28:1614–20.
   PubMed Web of Science ®Google Scholar
• Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature. 2010;464:917–21.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575–83.
   PubMed Web of Science ®Google Scholar
• Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376:66–70.
   PubMed Web of Science ®Google Scholar
• Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol. 2001;33:409–20.
   PubMed Web of Science ®Google Scholar
• Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5:74–80.
   PubMed Web of Science ®Google Scholar
• Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol. 2005;25:2441–9.
   PubMed Web of Science ®Google Scholar
• Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998;282:946–9.
   PubMed Web of Science ®Google Scholar
• Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res. 2007;67:593–9.
   PubMed Web of Science ®Google Scholar
• Galvagni F, Pennacchini S, Salameh A, Rocchigiani M, Neri F, Orlandini M, Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ Res. 2010;106:1839–48.
   PubMedGoogle Scholar
• Dixelius J, Makinen T, Wirzenius M, Karkkainen MJ, Wernstedt C, Alitalo K, Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem. 2003;278:40973–9.
   PubMed Web of Science ®Google Scholar
• Ito N, Wernstedt C, Engstrom U, Claesson-Welsh L. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J Biol Chem. 1998;273:23410–18.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Bohman S, Dixelius J, Berge T, Dimberg A, Magnusson P, VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 2005;24:2342–53.
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci USA. 2005;102:1076–81.
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008;266:37–52.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
   PubMed Web of Science ®Google Scholar
• Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L. Vascular endothelial growth factors and receptors; anti-angiogenic therapy in treatment of cancer. Mol Aspects Med. 2011;32:88–111.
   PubMed Web of Science ®Google Scholar
• Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362:841–4.
   PubMed Web of Science ®Google Scholar
• Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 1999;59:5209–18.
   PubMed Web of Science ®Google Scholar
• Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer. 2000;89:488–99.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Hattori K, Zhang H, Jimenez X, Ludwig DL, Dias S, Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity. Leukemia. 2003;17:604–11.
   PubMed Web of Science ®Google Scholar
• Krupitskaya Y, Wakelee HA. Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer. Curr Opin Investig Drugs. 2009;10:597–605.
   PubMed Web of Science ®Google Scholar
• Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2:REVIEWS3005.
   PubMed Web of Science ®Google Scholar
• Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein—basic fibroblast growth factor—is stored within basement membrane. Am J Pathol. 1988;130:393–400.
   PubMed Web of Science ®Google Scholar
• Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic. 2005;6:607–14.
   PubMed Web of Science ®Google Scholar
• Olsnes S, Klingenberg O, Wiedlocha A. Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol Rev. 2003;83:163–82.
   PubMed Web of Science ®Google Scholar
• Wesche J, Haglund K, Haugsten EM. Fibroblast growth factors and their receptors in cancer. Biochem J. 2011;437:199–213.
   PubMed Web of Science ®Google Scholar
• Coombe DR. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol Cell Biol. 2008;86:598–607.
   PubMed Web of Science ®Google Scholar
• Chen L, Deng CX. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci. 2005;10:1961–76.
   PubMed Web of Science ®Google Scholar
• Magnusson PU, Dimberg A, Mellberg S, Lukinius A, Claesson-Welsh L. FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin. Blood. 2007;110:4214–22.
   PubMed Web of Science ®Google Scholar
• Rusnati M, Presta M. Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des. 2007;13:2025–44.
   PubMed Web of Science ®Google Scholar
• Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004;15:197–204.
   PubMed Web of Science ®Google Scholar
• Ostman A, Heldin CH. PDGF receptors as targets in tumor treatment. Adv Cancer Res. 2007;97:247–74.
   PubMed Web of Science ®Google Scholar
• Terracio L, Ronnstrand L, Tingstrom A, Rubin K, Claesson-Welsh L, Funa K, Induction of platelet-derived growth factor receptor expression in smooth muscle cells and fibroblasts upon tissue culturing. J Cell Biol. 1988;107:1947–57.
   PubMed Web of Science ®Google Scholar
• Rolny C, Nilsson I, Magnusson P, Armulik A, Jakobsson L, Wentzel P, Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation. Blood. 2006;108:1877–86.
   PubMed Web of Science ®Google Scholar
• Streuli CH, Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem J. 2009;418:491–506.
   PubMed Web of Science ®Google Scholar
• Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996;85:863–73.
   PubMed Web of Science ®Google Scholar
• Ding H, Wu X, Bostrom H, Kim I, Wong N, Tsoi B, A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat Genet. 2004;36:1111–16.
   PubMed Web of Science ®Google Scholar
• Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development. 1997;124:2691–700.
   PubMed Web of Science ®Google Scholar
• Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994;8:1888–96.
   PubMed Web of Science ®Google Scholar
• Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277:242–5.
   PubMed Web of Science ®Google Scholar
• Leveen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994;8:1875–87.
   PubMed Web of Science ®Google Scholar
• Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature. 2008;456:809–13.
   PubMed Web of Science ®Google Scholar
• Heuchel R, Berg A, Tallquist M, Ahlen K, Reed RK, Rubin K, Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling. Proc Natl Acad Sci USA. 1999;96:11410–15.
   PubMed Web of Science ®Google Scholar
• Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003;111:1287–95.
   PubMed Web of Science ®Google Scholar
• Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 2008;8:579–91.
   PubMed Web of Science ®Google Scholar
• Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 2009;15:232–9.
   PubMed Web of Science ®Google Scholar
• Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009;15:220–31.
   PubMed Web of Science ®Google Scholar
• Abdollahi A, Folkman J. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. Drug Resist Updat. 2010;13:16–28.
   PubMed Web of Science ®Google Scholar
• Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 1999;284:808–12.
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010;468:824–8.
   PubMed Web of Science ®Google Scholar
• Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005;8:299–309.
   PubMed Web of Science ®Google Scholar
• Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell. 2009;15:21–34.
   PubMed Web of Science ®Google Scholar
• Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121:335–48.
   PubMed Web of Science ®Google Scholar
• Leite de Oliveira R, Hamm A, Mazzone M. Growing tumor vessels: more than one way to skin a cat—implications for angiogenesis targeted cancer therapies. Mol Aspects Med. 2011;32:71–87.
   PubMed Web of Science ®Google Scholar
• Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007;11:83–95.
   PubMed Web of Science ®Google Scholar
• Rini BI, Michaelson MD, Rosenberg JE, Bukowski RM, Sosman JA, Stadler WM, Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma. J Clin Oncol. 2008;26:3743–8.
   PubMed Web of Science ®Google Scholar
• Buckanovich RJ, Sasaroli D, O'Brien-Jenkins A, Botbyl J, Hammond R, Katsaros D, Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol. 2007;25:852–61.
   PubMed Web of Science ®Google Scholar
• St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Genes expressed in human tumor endothelium. Science. 2000;289:1197–202.
   PubMed Web of Science ®Google Scholar
• Yazici S, Kim SJ, Busby JE, He J, Thaker P, Yokoi K, Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice. Prostate. 2005;65:203–15.
   PubMed Web of Science ®Google Scholar